Mutations of optineurin in amyotrophic lateral sclerosis
- PMID: 20428114
- DOI: 10.1038/nature08971
Mutations of optineurin in amyotrophic lateral sclerosis
Abstract
Amyotrophic lateral sclerosis (ALS) has its onset in middle age and is a progressive disorder characterized by degeneration of motor neurons of the primary motor cortex, brainstem and spinal cord. Most cases of ALS are sporadic, but about 10% are familial. Genes known to cause classic familial ALS (FALS) are superoxide dismutase 1 (SOD1), ANG encoding angiogenin, TARDP encoding transactive response (TAR) DNA-binding protein TDP-43 (ref. 4) and fused in sarcoma/translated in liposarcoma (FUS, also known as TLS). However, these genetic defects occur in only about 20-30% of cases of FALS, and most genes causing FALS are unknown. Here we show that there are mutations in the gene encoding optineurin (OPTN), earlier reported to be a causative gene of primary open-angle glaucoma (POAG), in patients with ALS. We found three types of mutation of OPTN: a homozygous deletion of exon 5, a homozygous Q398X nonsense mutation and a heterozygous E478G missense mutation within its ubiquitin-binding domain. Analysis of cell transfection showed that the nonsense and missense mutations of OPTN abolished the inhibition of activation of nuclear factor kappa B (NF-kappaB), and the E478G mutation revealed a cytoplasmic distribution different from that of the wild type or a POAG mutation. A case with the E478G mutation showed OPTN-immunoreactive cytoplasmic inclusions. Furthermore, TDP-43- or SOD1-positive inclusions of sporadic and SOD1 cases of ALS were also noticeably immunolabelled by anti-OPTN antibodies. Our findings strongly suggest that OPTN is involved in the pathogenesis of ALS. They also indicate that NF-kappaB inhibitors could be used to treat ALS and that transgenic mice bearing various mutations of OPTN will be relevant in developing new drugs for this disorder.
Similar articles
-
Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.Neuropathology. 2016 Apr;36(2):125-34. doi: 10.1111/neup.12240. Epub 2015 Aug 24. Neuropathology. 2016. PMID: 26303227
-
Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.Autophagy. 2015 Apr 3;11(4):685-700. doi: 10.4161/auto.36098. Autophagy. 2015. PMID: 25484089 Free PMC article.
-
Optineurin and amyotrophic lateral sclerosis.Geriatr Gerontol Int. 2013 Jul;13(3):528-32. doi: 10.1111/ggi.12022. Epub 2012 Dec 26. Geriatr Gerontol Int. 2013. PMID: 23279185 Review.
-
[Identification of a new causative gene of amyotrophic lateral sclerosis; optineurin].Rinsho Shinkeigaku. 2012;52(1):1-5. doi: 10.5692/clinicalneurol.52.1. Rinsho Shinkeigaku. 2012. PMID: 22260971 Review. Japanese.
-
Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.Acta Neuropathol. 2011 Apr;121(4):519-27. doi: 10.1007/s00401-011-0813-3. Epub 2011 Mar 1. Acta Neuropathol. 2011. PMID: 21360076
Cited by
-
Genetic diagnosis and detection rates using C9orf72 repeat expansion and a multi-gene panel in amyotrophic lateral sclerosis.J Neurol. 2024 Apr 16. doi: 10.1007/s00415-024-12368-3. Online ahead of print. J Neurol. 2024. PMID: 38625400
-
Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration.bioRxiv [Preprint]. 2024 Apr 3:2024.04.02.587832. doi: 10.1101/2024.04.02.587832. bioRxiv. 2024. PMID: 38617277 Free PMC article. Preprint.
-
Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes.Biomolecules. 2024 Mar 20;14(3):377. doi: 10.3390/biom14030377. Biomolecules. 2024. PMID: 38540795 Free PMC article. Review.
-
Target Identification of a Class of Pyrazolone Protein Aggregation Inhibitor Therapeutics for Amyotrophic Lateral Sclerosis.ACS Cent Sci. 2023 Dec 20;10(1):87-103. doi: 10.1021/acscentsci.3c00213. eCollection 2024 Jan 24. ACS Cent Sci. 2023. PMID: 38292603 Free PMC article.
-
Primary Lateral Sclerosis: An Overview.J Clin Med. 2024 Jan 19;13(2):578. doi: 10.3390/jcm13020578. J Clin Med. 2024. PMID: 38276084 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous